Live from the NIH registry
Studies recruiting near Ogden right now
Top 25 of 111 recruiting studies, sorted by proximity — each links to its official registry page
Adaptation and Pilot Implementation of ePNa Clinical Decision Support for Utah Urgent Care Clinics
Pneumonia
N/A
Interventional 4,000 participants sought
South Ogden Instacare — South Ogden, Utah (2.5 mi)
· Sponsor: Intermountain Health Care, Inc.
A Study to Investigate Efficacy and Safety of Brivekimig in Participants With Crohn's Disease
Crohn's Disease
Phase 2
Interventional 99 participants sought
Investigational Site Number: 8400016 — Ogden, Utah (0.4 mi)
· Sponsor: Sanofi
Combination Antibiotic Therapy for Staphylococcus Aureus Bacteremia
Staphylococcus Aureus Bacteremia
Phase 4
Interventional 2,096 participants sought
McKay-Dee Hospital — Ogden, Utah (0.4 mi)
· Sponsor: Intermountain Health Care, Inc.
Brexanolone Lifting Outcomes Of Moms
Depression, Postpartum, Postpartum Depression (PPD)
Phase 3
Interventional 120 participants sought
Lipocine Investigational Site — Clinton, Utah (7.4 mi)
· Sponsor: Lipocine Inc.
A Study of Brenipatide in Participants With Moderate-to-Severe Alcohol Use Disorder
Alcohol Use Disorder
Phase 3
Interventional 1,100 participants sought
Alpine Research Organization — Clinton, Utah (7.4 mi)
· Sponsor: Eli Lilly and Company
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
Intracranial Meningioma, Recurrent Meningioma
Phase 2
Interventional 124 participants sought
Farmington Health Center — Farmington, Utah (17.6 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
Metabolic Dysfunction-Associated Steatotic Liver Disease
Phase 3
Interventional 4,500 participants sought
Care Access - Ogden — Ogden, Utah (0.4 mi)
· Sponsor: Eli Lilly and Company
Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 Diabetes
Diabetes Mellitus, Type 1
Phase 3
Interventional 150 participants sought
Advanced Research Institute - Ogden — Ogden, Utah (0.4 mi)
· Sponsor: vTv Therapeutics
Study to Evaluate the Efficacy and Safety of Oral Rilzabrutinib in Adults With Immune Thrombocytopenia (ITP) Who Failed First-line Treatment
Immune Thrombocytopenia
Phase 3
Interventional 60 participants sought
Community Cancer Trials of Utah-Investigational Site Number: 8400002 — Ogden, Utah (0.4 mi)
· Sponsor: Sanofi
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
Migraine
Phase 3
Interventional 1,059 participants sought
Pantheon Clinical Research /ID# 250703 — Bountiful, Utah (23.8 mi)
· Sponsor: AbbVie
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
NASH With Fibrosis, MASH With Fibrosis
Phase 3
Interventional 1,650 participants sought
Akero Clinical Study Site — Ogden, Utah (0.4 mi)
· Sponsor: Akero Therapeutics, Inc
Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation
Atrial Fibrillation (AF)
Phase 2
Interventional 1,200 participants sought
Alpine Research TC — Clinton, Utah (7.4 mi)
· Sponsor: Regeneron Pharmaceuticals
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Stage I Breast Cancer
Phase 3
Interventional 1,670 participants sought
McKay-Dee Hospital Center — Ogden, Utah (0.4 mi)
· Sponsor: NRG Oncology
Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With Moderate to Severe Acne
Acne
Phase 1, Phase 2
Interventional 800 participants sought
Alpine Research Association- Site Number : 8400050 — Layton, Utah (11.6 mi)
· Sponsor: Sanofi Pasteur, a Sanofi Company
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Stage III Colon Cancer
Phase 2, Phase 3
Interventional 1,912 participants sought
McKay-Dee Hospital Center — Ogden, Utah (0.4 mi)
· Sponsor: NRG Oncology
Clinical Outcomes of Bilateral Clareon Vivity in Post-Refractive Patients
Correction Vision Surgery, Cataract Surgery
N/A
Observational 35 participants sought
Utah Eye Centers — Ogden, Utah (0.4 mi)
· Sponsor: Utah Eye Centers
Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors
Metastatic Malignant Neoplasm in the Liver, Pancreatic Neuroendocrine Tumor
Phase 2
Interventional 141 participants sought
Farmington Health Center — Farmington, Utah (17.6 mi)
· Sponsor: SWOG Cancer Research Network
Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
Crohn's Disease
Phase 2
Interventional 590 participants sought
Care Access - Ogden /ID# 266428 — Ogden, Utah (0.4 mi)
· Sponsor: AbbVie
A Study to Investigate the Efficacy and Safety of SAR442970 in Adult Participants With Ulcerative Colitis
Ulcerative Colitis
Phase 2
Interventional 99 participants sought
Investigational Site Number: 8400007 — Ogden, Utah (0.4 mi)
· Sponsor: Sanofi
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
Chronic Obstructive Pulmonary Disease (COPD)
Phase 3
Interventional 990 participants sought
Research Site — Clearfield, Utah (8.6 mi)
· Sponsor: AstraZeneca
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
Elevated Lp(a), Atherosclerotic Cardiovascular Disease (ASCVD)
Phase 3
Interventional 10,450 participants sought
Ogden Clinic - Canyon View — Ogden, Utah (0.4 mi)
· Sponsor: Eli Lilly and Company
A Study on the Efficacy of a Vaccine Against Influenza in Adults ≥65 Years of Age
Influenza, Human
Phase 3
Interventional 54,000 participants sought
GSK Investigational Site — South Ogden, Utah (2.5 mi)
· Sponsor: GlaxoSmithKline
Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study
Migraine
Phase 4
Interventional 1,335 participants sought
Advanced Research Institute Ogden — Ogden, Utah (0.4 mi)
· Sponsor: Mayo Clinic
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
Cardiovascular Disease
Phase 3
Interventional 15,100 participants sought
Research Site — Ogden, Utah (0.4 mi)
· Sponsor: AstraZeneca
Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
Obesity With Diabetes, Overweight With Diabetes
Phase 3
Interventional 1,156 participants sought
Kailera Clinical Site — Pleasant View, Utah (6.4 mi)
· Sponsor: Kailera